2,281 Shares in Danaher Corporation $DHR Acquired by Divergent Planning LLC

Key Points

• Divergent Planning LLC acquired 2,281 shares of Danaher Corporation, valued at approximately $451,000, enhancing its stake in the company during the second quarter.
• Danaher reported earnings of $1.80 EPS for the last quarter, exceeding analysts' expectations of $1.64, with a quarterly revenue of $5.94 billion.
• The company announced a quarterly dividend of $0.32 per share, set to be paid on October 31st, representing an annualized dividend yield of 0.6%.

Divergent Planning LLC acquired a new position in Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,281 shares of the conglomerate's stock, valued at approximately $451,000.

Other hedge funds also recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. lifted its holdings in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares during the period. Sierra Ocean LLC raised its position in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after acquiring an additional 76 shares in the last quarter. Red Tortoise LLC lifted its holdings in Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate's stock valued at $30,000 after acquiring an additional 98 shares during the period. Smallwood Wealth Investment Management LLC purchased a new stake in Danaher in the 1st quarter worth approximately $31,000. Finally, Ramirez Asset Management Inc. acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $40,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Down 0.5%

Shares of DHR opened at $208.06 on Tuesday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $274.21. The stock has a market cap of $148.98 billion, a PE ratio of 44.27, a price-to-earnings-growth ratio of 2.98 and a beta of 0.77. The firm's fifty day moving average is $201.76 and its two-hundred day moving average is $197.42. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.72 earnings per share. Research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher's payout ratio is currently 27.23%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Robert W. Baird boosted their target price on shares of Danaher from $229.00 to $236.00 and gave the company an "outperform" rating in a research note on Wednesday, October 15th. Evercore ISI raised their target price on Danaher from $226.00 to $245.00 and gave the company an "outperform" rating in a research report on Tuesday, October 7th. Rothschild & Co Redburn reaffirmed a "neutral" rating and issued a $220.00 price target (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Finally, Guggenheim restated a "buy" rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $245.00.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 11.20% of the stock is owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.